Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT

Journal of Nuclear Medicine

Volumn 48, Issue 7, 2007, Pages 1060-1068

  Büther, Florian ^a   Stegger, Lars ^a   Dawood, Mohammad ^a   Range, Felix ^a   Schäfers, Michael ^a   Fischbach, Roman ^a   Wichter, Thomas ^a   Schober, Otmar ^a   Schäfers, Klaus P ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Artifacts; Attenuation correction; Contrast agent; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPROMIDE;

ARTICLE; ARTIFACT REDUCTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE WALL; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOACTIVITY;

ARTIFACTS; CONTRAST MEDIA; CORONARY ARTERIOSCLEROSIS; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IOHEXOL; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447335331     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.039941     Document Type: Article

References (18)

1. Lang N, Dawood M, Büther F, Schober O, Schäfers M, Schäfers K. Organ movement reduction in PET/CT using dual-gated listmode acquisition. Z Med Phys. 2006;16:93-100.
2. Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med. 2003;33:166-179.
3. Büther F, Schäfers KP, Stegger L, et al. Artifacts caused by contrast agents and patient movement in cardiac PET/CT Nuklearmedizin. 2006;45:N53-N54.
4. Segars WP. Development of a New Dynamic NURBS-Based Cardiac-Torso (NCAT) Phantom [dissertation]. Chapel Hill, NC: University of North Carolina; 2001. Available at: www.bme.unc.edu/~wsegars/segars_NCAT_dis.pdf. Accessed May 7, 2007.
5. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
6. Burger C, Goerres G, Schoenes S, Buck A, Lonn AHR, von Schulthess GK. PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511 keV attenuation coefficients. Eur J Nucl Med Mol Imaging. 2002;29:922-927.
7. Bailey DL, Meikle SR. A convolution-subtraction scatter correction method for 3D PET. Phys Med Biol. 1994;39:411-424.
8. Stegger L, Hoffmeier AN, Schäfers KP, et al. Accurate noninvasive measurement of infarct size in mice with high-resolution PET. J Nucl Med. 2006;47:1837-1844.
9. 99mTc-MIBI SPECT: validation of an elastic surface model approach in comparison to cardiac magnetic resonance imaging, 4D-MSPECT and QGS. Eur J Nucl Med Mol Imaging. January 10, 2007 [Epub ahead of print].
10. Mawlawi O, Erasmus JJ, Munden RF, et al. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR. 2006;186:308-319.
11. Antoch G, Freudenberg LS, Egelhof T, et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med. 2002;43:1339-1342.
12. Antoch G, Jentzen W, Freudenberg LS, et al. Effects of oral contrast agents on computed tomography-based positron emission attenuation correction in dual-modality positron emission tomography/computed tomography imaging. Invest Radiol. 2003;38:784-789.
13. Dizendorf EV, Treyer V, von Schulthess GK, Hany TF. Application of oral contrast media in coregistered positron emission tomography-CT. AJR. 2002;179:477-481.
14. Dizendorf E, Hany TF, Buck A, von Schulthess GK, Burger C. Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med. 2003;44:732-738.
15. Cohade C, Osman M, Nakamoto Y, et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med. 2003;44:412-416.
16. Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Højgaard L. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging. 2005;32:1167-1175.
17. Yau Y, Chan W, Tam Y, et al. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med. 2005;46:283-291.
18. Nehmeh SA, Erdi YE, Kalagian H, et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. J Nucl Med. 2003;44:1940-1944.